{
  "directed": true,
  "multigraph": true,
  "graph": {
    "pybel_version": "0.13.1",
    "document_metadata": {
      "copyright": "Copyright Â© 2018 Fraunhofer Institute SCAI, All rights reserved.",
      "licenses": "CC BY-SA 4.0",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "name": "Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5",
      "version": "1.0.0",
      "authors": "Sandra Spalek",
      "description": ""
    },
    "namespace_url": {
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/mesh-names.belns",
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns",
      "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns",
      "NCBIGENE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns",
      "GFAM": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc.genefamily-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "MIRBASE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mirbase-names.belns",
      "HBP": "https://raw.githubusercontent.com/pharmacome/terminology/785431732a26d6809b4162d98b95687d16404e63/export/hbp.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns",
      "CTO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/clinical-trial-ontology/clinical-trial-ontology-1.0.0.belns",
      "DO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20170725.belns",
      "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns",
      "MGI": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mgi-mouse-genes/mgi-mouse-genes-20170725.belns",
      "RGD": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/rgd-rat-genes/rgd-rat-genes-20170725.belns",
      "SCOMP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-named-complexes/selventa-named-complexes-20170725.belns",
      "SFAM": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-protein-families/selventa-protein-families-20170725.belns",
      "INTERPRO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/interpro/interpro-20170731.belns"
    },
    "namespace_pattern": {
      "DBSNP": "rs[0-9]+",
      "TAXONOMY": "^\\d+$"
    },
    "namespaces_uncached": [],
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "Gender": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "annotation_pattern": {},
    "annotation_list": {},
    "path": "/Users/cthoyt/dev/hbp-knowledge/hbp_knowledge/baumann1993.bel"
  },
  "nodes": [
    {
      "function": "Abundance",
      "namespace": "GO",
      "name": "microtubule",
      "id": "0c753f37efe0eb149a47a1dd700eda093a03b462374275c68480b6aed3be0f81aa9793a179dfd97f8e0834f1fb9be4b4a6cff2165b176d9e8a8744f5e0d5bc2c"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "HBP00006",
      "id": "9b1d89d922db273dc91b96b20d332236f065e4b4c3d625fb7f3bb266d7559cfc3e316823ea339ea3dd3e4905c14ea1a3af7b7cf5551ffa2696a1fb7c2a6c5739"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "HBP00172",
      "id": "db6eca991deb3a59fb0633e05378ff9273fa350d21923bdf4b59bb818845e4b01d46e36f5eaa025ec748f7a6665509b07f2759061232fd6e7ea69cb8299a7939"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Abundance",
          "namespace": "HBP",
          "name": "HBP00172",
          "id": "db6eca991deb3a59fb0633e05378ff9273fa350d21923bdf4b59bb818845e4b01d46e36f5eaa025ec748f7a6665509b07f2759061232fd6e7ea69cb8299a7939"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "CDK5",
          "id": "a85beb5b2b9417fabbbcc2135b9533cb0766b38688caf02242632843ae455bad332fb625d6e8296ff77b40e841485a56854fc14e300552425d596e8a8e70fd3f"
        }
      ],
      "id": "d0984fbcfc223f9f22b239db7421a50ca20af50ed0c62c0c418d6208561d069732e762402bc0fffe15d47a3f44221e45c8607a3f7153d389a1cf5b469000eac9"
    },
    {
      "function": "Protein",
      "namespace": "HBP",
      "name": "HBP00053",
      "id": "6c6ee3b3feb8d0844995d487c8be19b6e29cb8c020b50c358d0ed5b2dd5e8f2a9be178fefd662871674aaeea3a3e8cc742e23a258890a1881bf8b8521adc5379"
    },
    {
      "function": "Protein",
      "namespace": "HBP",
      "name": "HBP00053",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ph"
          }
        }
      ],
      "id": "3465e9ec9585b01b49eb97e57923531e40794ba592d288e81ee361d2011fb42e61479873673ca24936a82a2b70ef4c48fba10678865717ef2a98bac378fa1bf2"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "CDK2",
      "id": "ad499bcb9c7ca2de8e3d699b60d3c3c75a3bfe51df16325064b57ad8de3442312f8213f77477e093234bd399a0c81575fdc0d2f9878d8cc7eedb3cca921efe2e"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "CDK5",
      "id": "a85beb5b2b9417fabbbcc2135b9533cb0766b38688caf02242632843ae455bad332fb625d6e8296ff77b40e841485a56854fc14e300552425d596e8a8e70fd3f"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ph"
          }
        }
      ],
      "id": "526bae251987f8c4f55f6e2451662fa55e087c57585beae7c389b020d73487c739834e9b8ec841783de6a5b5fb9df8b138e9eff4406a9ec5e606766575dcac0e"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ph"
          },
          "code": "Ser",
          "pos": 199
        }
      ],
      "id": "a145df05055e4436ddc08a7d9e576954162015f2fd2fa4cdbb4e673261fe4932313e7e8984a94c3d8624252ea9edb21bb2b1a15071d766a2ce5e919d17a2735c"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ph"
          },
          "code": "Ser",
          "pos": 202
        }
      ],
      "id": "49b56446b699c749fbb01c4560254bbf621f44bd52a02cb74e212fb0ef1b9b1616a31cfe6ca06023fee3689ef552a3e8fe71211987ebad4180c2d78535f4ad7a"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ph"
          },
          "code": "Ser",
          "pos": 235
        }
      ],
      "id": "56b559ea103ba90d8fd62e908303bb518afc413fa2e659f3043602e7e227a4f345231987467945e1a02d74aeb5a1840ec6759bdae3109cd4836894ddd9936f95"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ph"
          },
          "code": "Ser",
          "pos": 396
        }
      ],
      "id": "233ebce30d7505cee42acc956f9d268e5b725e14853bd56fab3b87a93a4e0c8141a6fdec062d10e9c4924f6e13a61184600872c2f5080656e3ca27227eb4cb93"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ph"
          },
          "code": "Ser",
          "pos": 404
        }
      ],
      "id": "a448f901ddc919f32d50fa5284355b4eb4ed52e9ebf8705052086706d728d8ebef0cc66616b7fbfda3aeffd49db6e41134fb39996aa9b996a73bce331de95767"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "PRKACA",
      "id": "1822e503df5a619b37063f0dabc67b9564a6e7ba2ae477dd5fb70c8996f53c0ba8242d64510a626c1b766ecdd1dd4f74cf39d7d49675cbba7d2fae2fa5c903b9"
    },
    {
      "function": "Protein",
      "namespace": "SFAM",
      "name": "GSK3 Family",
      "id": "cffea66847216ebd8da555d9de94f6b4589db341395576c270e80c495463de8fbc4753df7612cf9e11ef65cd844eae0c11e1ed6683839e5822d7e2b2e15b22fb"
    },
    {
      "function": "Protein",
      "namespace": "SFAM",
      "name": "MAPK Erk1/2 Family",
      "id": "24748836810901a2d8100c2e99523dac0507a3e00822967d45b4901a2b37b5442b899a09136aeabaef71d98c4cc4bc62a03649b4d0ec2925d29de58c4dc077e5"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Alzheimer Disease",
      "id": "00f72839b5d655cb4cb088b0eb8874bd406284d98a2afd0bdd73de0a34adb78af374b0eb26990387f41d3b41cda0e32c1b5ff5f86ed63d0fdc841bac17865541"
    },
    {
      "function": "Reaction",
      "reactants": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
        }
      ],
      "products": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "variants": [
            {
              "kind": "pmod",
              "identifier": {
                "namespace": "bel",
                "name": "Ph"
              }
            }
          ],
          "id": "526bae251987f8c4f55f6e2451662fa55e087c57585beae7c389b020d73487c739834e9b8ec841783de6a5b5fb9df8b138e9eff4406a9ec5e606766575dcac0e"
        }
      ],
      "id": "a844112ec2f1b740fe01c197021ee1258fa8bd9eaf2f9c4ea2190bc85dc5d967150ed5938d0e3346a079e726c6cbc11d3aee2337772d624bd6979752ba3e30ba"
    }
  ],
  "links": [
    {
      "line": 73,
      "relation": "directlyIncreases",
      "evidence": "The Mr shifts up with time in several stages, very similar to our earlier observations with the brain kinase activity, MAP kinase and GSK3 (Fig. 2,)",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 6,
      "target": 9,
      "key": "2e9f37caff30fcb0616a59c6655b54ca0d4d706abfeb377906050f31d7eec4dfbbba3783fdb0b88feb493df9b948caa5727c492a5d99474c409a703e52873937"
    },
    {
      "line": 84,
      "relation": "directlyIncreases",
      "evidence": "The diagnostic antibodies AT8, TAU-1, SM131, SM134, and SM133 react to phosphorylation similarly as with MAPK and GSK-3, indicating that SP motifs before the repeat region (S199 and/or S202, S235) and after the repeats (S396, S404) become phosphorylated (Fig. 2,-2,); note that AT8, SMUl, and SM134 react with PHFs where the epitopes containing SP motifs are phosphorylated, while TAU-1 and SM133 react with normal tau where the epitopes are not phosphorylated",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 6,
      "target": 10,
      "key": "496e3374babfbd24dfca507d6512f78d0066a2b743c301b59d049e1c19a4684d23013cfdfb4c831bb68eeb5a3cac22650eed4d52eb7ad72d6254be426f5ad9fd"
    },
    {
      "line": 122,
      "relation": "directlyIncreases",
      "evidence": "The reaction with the diagnostic antibodies (Fig. 4) is similar to the examples shown previously for cdk2 (Fig. 2), MAP kinase [8], or GSK-3 [26], indicating the phosphorylation of the SP motifs for which these antibodies are sensitive (serines 199, 202, 235, 396, 404; see Fig. 1)",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 6,
      "target": 10,
      "key": "50c7fd98a771d7c981681021bdbca5e2b1f15432c6e731e696e454f1d202c90deb9135c446eb8f9e6d46c0078ad810a6693717594fcbe9aa6d0175072eb7c82d"
    },
    {
      "line": 85,
      "relation": "directlyIncreases",
      "evidence": "The diagnostic antibodies AT8, TAU-1, SM131, SM134, and SM133 react to phosphorylation similarly as with MAPK and GSK-3, indicating that SP motifs before the repeat region (S199 and/or S202, S235) and after the repeats (S396, S404) become phosphorylated (Fig. 2,-2,); note that AT8, SMUl, and SM134 react with PHFs where the epitopes containing SP motifs are phosphorylated, while TAU-1 and SM133 react with normal tau where the epitopes are not phosphorylated",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 6,
      "target": 11,
      "key": "257f067956576b8ded8fc4ddeeb27b016fcebb7ceda364be72e6004724f2ac1cc6942f9c43ab595fcff800e100e0d6ff13f6c24b96764d12a0f4b0a6a040f0bb"
    },
    {
      "line": 123,
      "relation": "directlyIncreases",
      "evidence": "The reaction with the diagnostic antibodies (Fig. 4) is similar to the examples shown previously for cdk2 (Fig. 2), MAP kinase [8], or GSK-3 [26], indicating the phosphorylation of the SP motifs for which these antibodies are sensitive (serines 199, 202, 235, 396, 404; see Fig. 1)",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 6,
      "target": 11,
      "key": "46fa72122021ce71931d18159538f6097eca464edae1080f4aac055bded004c20d70a361ab177d4c77580d828e4eaa85aeed991efb2120e8cce80cb11a8c4202"
    },
    {
      "line": 86,
      "relation": "directlyIncreases",
      "evidence": "The diagnostic antibodies AT8, TAU-1, SM131, SM134, and SM133 react to phosphorylation similarly as with MAPK and GSK-3, indicating that SP motifs before the repeat region (S199 and/or S202, S235) and after the repeats (S396, S404) become phosphorylated (Fig. 2,-2,); note that AT8, SMUl, and SM134 react with PHFs where the epitopes containing SP motifs are phosphorylated, while TAU-1 and SM133 react with normal tau where the epitopes are not phosphorylated",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 6,
      "target": 12,
      "key": "83e7db45e12eca5c7d31885124bdb869e3b20aec06da67e36c0deab40d19e74df00da563c050e20a933717cef933b5bc79ef91b6901e7ea14955ad3703d995ae"
    },
    {
      "line": 124,
      "relation": "directlyIncreases",
      "evidence": "The reaction with the diagnostic antibodies (Fig. 4) is similar to the examples shown previously for cdk2 (Fig. 2), MAP kinase [8], or GSK-3 [26], indicating the phosphorylation of the SP motifs for which these antibodies are sensitive (serines 199, 202, 235, 396, 404; see Fig. 1)",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 6,
      "target": 12,
      "key": "67e02c065f8636eb15c108f39c0543517f1375a47350181e35eab24b8a900511c1d3fca325c554981c4526520b26fba565ccc89aa270b5a8fe502fe85c6175bf"
    },
    {
      "line": 87,
      "relation": "directlyIncreases",
      "evidence": "The diagnostic antibodies AT8, TAU-1, SM131, SM134, and SM133 react to phosphorylation similarly as with MAPK and GSK-3, indicating that SP motifs before the repeat region (S199 and/or S202, S235) and after the repeats (S396, S404) become phosphorylated (Fig. 2,-2,); note that AT8, SMUl, and SM134 react with PHFs where the epitopes containing SP motifs are phosphorylated, while TAU-1 and SM133 react with normal tau where the epitopes are not phosphorylated",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 6,
      "target": 13,
      "key": "33864912de465d13801db132d2fdf917d03ac8454252e5a669ed8b1ff9bc68774ee8998c643b008b6aa53b70d4c06d1116a86ae1734e1a5dc80f359d0e4ffd6c"
    },
    {
      "line": 125,
      "relation": "directlyIncreases",
      "evidence": "The reaction with the diagnostic antibodies (Fig. 4) is similar to the examples shown previously for cdk2 (Fig. 2), MAP kinase [8], or GSK-3 [26], indicating the phosphorylation of the SP motifs for which these antibodies are sensitive (serines 199, 202, 235, 396, 404; see Fig. 1)",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 6,
      "target": 13,
      "key": "9b443ad95d24a6661f210448c4ccab644d9ee520e838d88b3e793f6d607636c30a99c70be72a5d97be5b76e6e8a3c358ce0320886a7feab6176eddfd323c7322"
    },
    {
      "line": 88,
      "relation": "directlyIncreases",
      "evidence": "The diagnostic antibodies AT8, TAU-1, SM131, SM134, and SM133 react to phosphorylation similarly as with MAPK and GSK-3, indicating that SP motifs before the repeat region (S199 and/or S202, S235) and after the repeats (S396, S404) become phosphorylated (Fig. 2,-2,); note that AT8, SMUl, and SM134 react with PHFs where the epitopes containing SP motifs are phosphorylated, while TAU-1 and SM133 react with normal tau where the epitopes are not phosphorylated",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 6,
      "target": 14,
      "key": "57c09bf062fa090778d134842ac3478f1f2e3ca1a394ef9390b847b8d930f095eacd299c45f73a4e5d326382b3ce1f6d28a4f43f5239a5e92c5db59310a117b3"
    },
    {
      "line": 126,
      "relation": "directlyIncreases",
      "evidence": "The reaction with the diagnostic antibodies (Fig. 4) is similar to the examples shown previously for cdk2 (Fig. 2), MAP kinase [8], or GSK-3 [26], indicating the phosphorylation of the SP motifs for which these antibodies are sensitive (serines 199, 202, 235, 396, 404; see Fig. 1)",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 6,
      "target": 14,
      "key": "74e43a8ccf0a0c79ac29b4b40a082b58c50fd4dc1046f9e6e5d1b51dc493f4ad98194fb5fe96fa46bc537cb2d023b20d9c7da4cb8450a20732643b97209980fb"
    },
    {
      "line": 170,
      "relation": "positiveCorrelation",
      "evidence": "Thus, we now know three kinases, cdk5, MAP kinase, and GSK-3, all of which are present in neurons, which are capable of transforming tau into the Alzheimer-like state, and therefore could account for the pathological phosphorylation of tau in Alzheimer brains",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Confidence": {
          "High": true
        }
      },
      "source": 9,
      "target": 18,
      "key": "0c13e6df5b4db3063c9d8d9318ce3b5ff0bdbd2e0d6f5590b78d405a7c8ab2a91bb07b4d37bf3a4f54ad4ec890560ededf229a80806dd44023ba08571b9add95"
    },
    {
      "relation": "hasVariant",
      "source": 8,
      "target": 9,
      "key": "c4e71f1866eab20795e7e1d4b54fe09effb8b376e41712f8a130fe5192e07d83b0749cc2e2297b62cbea4bb7b1033909ea6d6423fa06166cb07543cee4249d48"
    },
    {
      "relation": "hasVariant",
      "source": 8,
      "target": 10,
      "key": "3dd217dbf24e05387967c81e77bc580eae4bb79dbbaa0ec812338e6abafcc6f5c8365a7efe2732b7e571e9e3cec08e53f75be35fb922dff737ec143c8103218b"
    },
    {
      "relation": "hasVariant",
      "source": 8,
      "target": 11,
      "key": "57f6dfc4cb18d002fb185a5f8ddb26897f5c0e93f59d9f1ee55374a026a04da6c975e40dd70e3f890ef9f9793c8b77bf916ea47533ecfee045a95797915ad8ba"
    },
    {
      "relation": "hasVariant",
      "source": 8,
      "target": 12,
      "key": "3a92d83cf4f01b5d9f4ae62a3edc3e4a042a47a573fa4b50cb6d784ff585d49dd9aeaba4095ff2e3f02430ffaf3ac3aa1ed0dfe5af3a57a673725f8886e4a800"
    },
    {
      "relation": "hasVariant",
      "source": 8,
      "target": 13,
      "key": "09505215df0db1264915198df6f54ea647eb376b6ede05f22846b2d289a2907fa049769b8eb45a919e706a2eb7c7a96704537753eeb5e7c30a012888cd5296de"
    },
    {
      "relation": "hasVariant",
      "source": 8,
      "target": 14,
      "key": "50403cc7ef5ce4172930d644a5740cda8918061439e7d529c0f888ba1b049a77a5339ec7d3482657b832429d9e62714c7fafa0d13366824ad8debfc61eaefc20"
    },
    {
      "line": 74,
      "relation": "directlyIncreases",
      "evidence": "The Mr shifts up with time in several stages, very similar to our earlier observations with the brain kinase activity, MAP kinase and GSK3 (Fig. 2,)",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 17,
      "target": 9,
      "key": "21a769378f746bde861390d5e4fb7e8c92e475f656373be051491417fb8c646904ec90dde422f77e2c9f439b067d4e06d883ca18e317a1df9daacfd700ab24e1"
    },
    {
      "line": 132,
      "relation": "directlyIncreases",
      "evidence": "The reaction with the diagnostic antibodies (Fig. 4) is similar to the examples shown previously for cdk2 (Fig. 2), MAP kinase [8], or GSK-3 [26], indicating the phosphorylation of the SP motifs for which these antibodies are sensitive (serines 199, 202, 235, 396, 404; see Fig. 1)",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 17,
      "target": 10,
      "key": "860ba5d1284a25bec6b5d5668d27072982a8e1832e4196324b264ac90b0925d121886835c7c2457c70152730b808afddface72fd58f12a00e0b3815f4b950d43"
    },
    {
      "line": 133,
      "relation": "directlyIncreases",
      "evidence": "The reaction with the diagnostic antibodies (Fig. 4) is similar to the examples shown previously for cdk2 (Fig. 2), MAP kinase [8], or GSK-3 [26], indicating the phosphorylation of the SP motifs for which these antibodies are sensitive (serines 199, 202, 235, 396, 404; see Fig. 1)",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 17,
      "target": 11,
      "key": "eb9c409887dbdc6d95572db7f9630ec9daf3c298930a43eb96e42477a31af2c52f811c7d8f70f33d0ab4fdc064c50112ee735987132268f371397b7f459a7416"
    },
    {
      "line": 134,
      "relation": "directlyIncreases",
      "evidence": "The reaction with the diagnostic antibodies (Fig. 4) is similar to the examples shown previously for cdk2 (Fig. 2), MAP kinase [8], or GSK-3 [26], indicating the phosphorylation of the SP motifs for which these antibodies are sensitive (serines 199, 202, 235, 396, 404; see Fig. 1)",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 17,
      "target": 12,
      "key": "47812d3a37ba8c3be7c6085521b565c34bb36b69e409ac2796c27e43e87c7a9ca55d18b1504bab50e1696b983b6cf088aff48c3cbddbdc30da527673411f4053"
    },
    {
      "line": 135,
      "relation": "directlyIncreases",
      "evidence": "The reaction with the diagnostic antibodies (Fig. 4) is similar to the examples shown previously for cdk2 (Fig. 2), MAP kinase [8], or GSK-3 [26], indicating the phosphorylation of the SP motifs for which these antibodies are sensitive (serines 199, 202, 235, 396, 404; see Fig. 1)",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 17,
      "target": 13,
      "key": "0d4dd66644af5cbf5bebb4f353d1228fb0a875b32032ca53f970c11fdd83765058018358b8db709d184565bcaa996212cd4415bc223cb1d51ddb7b525e857070"
    },
    {
      "line": 136,
      "relation": "directlyIncreases",
      "evidence": "The reaction with the diagnostic antibodies (Fig. 4) is similar to the examples shown previously for cdk2 (Fig. 2), MAP kinase [8], or GSK-3 [26], indicating the phosphorylation of the SP motifs for which these antibodies are sensitive (serines 199, 202, 235, 396, 404; see Fig. 1)",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 17,
      "target": 14,
      "key": "8ff9a786772ccb2401863f964f47bbb99e2367593d10f277d54e48cd994e4b507b17849a413aae0feafff940a1ade0ffaafd91e1ec002e8008c32ec72e483b71"
    },
    {
      "line": 158,
      "relation": "association",
      "evidence": "In this regard, cdk5 is similar to PKA [30], MAP kinase, and GSK-3 [12,17,26], but distinct from PKC or CaMK which do not copurify with microtubules [34]",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 17,
      "target": 0,
      "key": "4bb6eb14d2f5aa14ec118ecaeb9f48e91cc9cf7aa2239cfc0b3d5cdc66d5867da4279a617538c1d6056481abe488e5613c9d741b5688684f8095cf269f08b6ac"
    },
    {
      "line": 159,
      "relation": "association",
      "evidence": "In this regard, cdk5 is similar to PKA [30], MAP kinase, and GSK-3 [12,17,26], but distinct from PKC or CaMK which do not copurify with microtubules [34]",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 17,
      "target": 1,
      "key": "78d5b8cbc100976ed62d317a7cccdf41a79f5fac0ffce82dad5e89fed0af2e66700d7c048c4e8b13857920f8fb6c21020a78469dca37b925075bf237e2d65d52"
    },
    {
      "line": 172,
      "relation": "increases",
      "evidence": "Thus, we now know three kinases, cdk5, MAP kinase, and GSK-3, all of which are present in neurons, which are capable of transforming tau into the Alzheimer-like state, and therefore could account for the pathological phosphorylation of tau in Alzheimer brains",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Confidence": {
          "High": true
        }
      },
      "source": 17,
      "target": 19,
      "key": "d8efaec6d2b5b716150c71a60e31c61c42c6bf7acd4d25a53a4c623222a0e91456d34c0be50e0a6ffac1170b8ab08f014357f9502ff3d5a8a43256417a2b5590"
    },
    {
      "line": 173,
      "relation": "positiveCorrelation",
      "evidence": "Thus, we now know three kinases, cdk5, MAP kinase, and GSK-3, all of which are present in neurons, which are capable of transforming tau into the Alzheimer-like state, and therefore could account for the pathological phosphorylation of tau in Alzheimer brains",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Confidence": {
          "High": true
        }
      },
      "source": 17,
      "target": 18,
      "key": "cbc550909d2de7bbeb54bd1389d29bd2b1aee34da5378f29f01b754d4b2c8b4767718e7a6e810626978e82bdbfbe66c3801f1edf7504dcf9ea1f2a15655c5b9f"
    },
    {
      "line": 75,
      "relation": "directlyIncreases",
      "evidence": "The Mr shifts up with time in several stages, very similar to our earlier observations with the brain kinase activity, MAP kinase and GSK3 (Fig. 2,)",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 16,
      "target": 9,
      "key": "7d6ea414c0f00153c6a5b0b79560f003f66d29764a6c8c80e6b72edb4ada3d571947de0c089a2097c3cb1133b08c060b1d3633a22a01b97d6332921542bee5db"
    },
    {
      "line": 137,
      "relation": "directlyIncreases",
      "evidence": "The reaction with the diagnostic antibodies (Fig. 4) is similar to the examples shown previously for cdk2 (Fig. 2), MAP kinase [8], or GSK-3 [26], indicating the phosphorylation of the SP motifs for which these antibodies are sensitive (serines 199, 202, 235, 396, 404; see Fig. 1)",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 16,
      "target": 10,
      "key": "a23665276323315bad65ae84eaa4eba5d18a47f56ef0179ec07e4886d203e0cebf8aeb56e056cfc2dd1bbd80dacabf4c2c7744c47758a4ac298cc67898c9a7cf"
    },
    {
      "line": 138,
      "relation": "directlyIncreases",
      "evidence": "The reaction with the diagnostic antibodies (Fig. 4) is similar to the examples shown previously for cdk2 (Fig. 2), MAP kinase [8], or GSK-3 [26], indicating the phosphorylation of the SP motifs for which these antibodies are sensitive (serines 199, 202, 235, 396, 404; see Fig. 1)",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 16,
      "target": 11,
      "key": "a76b673f202266dc239e88842a64fab3005b756206e593a6c38852995b72787ba782a2e5315c09d89b725f2d61c7cf5bc996db2f7468a78910f1468a5829ad68"
    },
    {
      "line": 139,
      "relation": "directlyIncreases",
      "evidence": "The reaction with the diagnostic antibodies (Fig. 4) is similar to the examples shown previously for cdk2 (Fig. 2), MAP kinase [8], or GSK-3 [26], indicating the phosphorylation of the SP motifs for which these antibodies are sensitive (serines 199, 202, 235, 396, 404; see Fig. 1)",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 16,
      "target": 12,
      "key": "099b19118994618c7c0e514f2313810467bca0eb26626d704e7cb36da00c1fe448f3b575f6340814ed62ea4181d897f44bc528afb054e1bfbd93312cbdc263f3"
    },
    {
      "line": 140,
      "relation": "directlyIncreases",
      "evidence": "The reaction with the diagnostic antibodies (Fig. 4) is similar to the examples shown previously for cdk2 (Fig. 2), MAP kinase [8], or GSK-3 [26], indicating the phosphorylation of the SP motifs for which these antibodies are sensitive (serines 199, 202, 235, 396, 404; see Fig. 1)",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 16,
      "target": 13,
      "key": "9af0e3fcabb6682636d4ecb220dfbeae782fc2d9815e735effdd5f5c06a2f8e7b6507931442ba1c4004aa26c675ba5bd900a3727204552d6dd5ba23ca083cb53"
    },
    {
      "line": 141,
      "relation": "directlyIncreases",
      "evidence": "The reaction with the diagnostic antibodies (Fig. 4) is similar to the examples shown previously for cdk2 (Fig. 2), MAP kinase [8], or GSK-3 [26], indicating the phosphorylation of the SP motifs for which these antibodies are sensitive (serines 199, 202, 235, 396, 404; see Fig. 1)",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 16,
      "target": 14,
      "key": "8ac06ea3c47223594bcf17bd04167603bc74c13b9e96918f1da866f3c4126e202c4ec887f7187b2887d4edc2883bdd8f9c57490c956173581a00a63dae823f40"
    },
    {
      "line": 160,
      "relation": "association",
      "evidence": "In this regard, cdk5 is similar to PKA [30], MAP kinase, and GSK-3 [12,17,26], but distinct from PKC or CaMK which do not copurify with microtubules [34]",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 16,
      "target": 0,
      "key": "9aa7a384df8fcb18a0faf112f8d1bac140b1cb9c6c1a2821d9ec03ed13b75a46979d98f86c493cfa0802b5bde6d5e805eb9f822be7d402a9c0278a83ec66e60b"
    },
    {
      "line": 161,
      "relation": "association",
      "evidence": "In this regard, cdk5 is similar to PKA [30], MAP kinase, and GSK-3 [12,17,26], but distinct from PKC or CaMK which do not copurify with microtubules [34]",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 16,
      "target": 1,
      "key": "165056351b0aa87c5e096ce4c77f7be59822c1f71ab74ff7f182afa88c042d74602a617bacab3be54836f9c1b805f215f2aa120814fd60ad6c11fc8efa382e70"
    },
    {
      "line": 174,
      "relation": "increases",
      "evidence": "Thus, we now know three kinases, cdk5, MAP kinase, and GSK-3, all of which are present in neurons, which are capable of transforming tau into the Alzheimer-like state, and therefore could account for the pathological phosphorylation of tau in Alzheimer brains",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Confidence": {
          "High": true
        }
      },
      "source": 16,
      "target": 19,
      "key": "ec34bafc72a5078e93725331788fd42a78963612573c884ac3d644a980fc189b02468072f3a4aac3592e3ad423c2fcc74265349f05f908a9614434078fcd2a87"
    },
    {
      "line": 175,
      "relation": "positiveCorrelation",
      "evidence": "Thus, we now know three kinases, cdk5, MAP kinase, and GSK-3, all of which are present in neurons, which are capable of transforming tau into the Alzheimer-like state, and therefore could account for the pathological phosphorylation of tau in Alzheimer brains",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Confidence": {
          "High": true
        }
      },
      "source": 16,
      "target": 18,
      "key": "9d673e1425c2d029570b053ed47c2e51e7117bd5bb3eac8f40a0d264d39ca057dd0dec40d30e17e4cc0fa059f76313ebf5b791e030189326df8a5d16035ac42c"
    },
    {
      "line": 97,
      "relation": "directlyIncreases",
      "evidence": "These fractions (7-9) contained several protein bands, including two with Mr = 25 and 31 kDa (Fig. 3D, lanes 3-5) and were capable of phosphorylating htau40, incorporating 3.2, 4.2 and 2.9 mol Pi per mol htau40, respectively, and inducing an A4, shift of htau40 in SDS-PAGE",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 7,
      "target": 5,
      "key": "1acebd13bd7da19eafe3264d1f2daad35022853b1e317e800993818f695e3853b25bfd1ef381738cc089c1318c1651bdcd99cb0925c1f2b4cc7fa701a8ac089c"
    },
    {
      "line": 107,
      "relation": "directlyIncreases",
      "evidence": "In conclusion, this cdc2-like kinase activity towards tau occurs in brain tissue and has an Mr of 31 kDa. These features are suggestive of other cdc2-like kinases cloned recently from brain, termed nclk [ 141, PSSARLE [28], or cdk5 [42,49]. Indeed, the 31 kDa protein reacted with an antibody specific for cdk5. Thus, the kinase isolated here is very similar if not identical to cdk5.",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "source": 7,
      "target": 9,
      "key": "04b5db7c0ae041caa6bb9b4af97179369031af31ca2e418bfc8cc1cc2544efe304eebc28781cbeb75bc5be212c698724e7359018ebb254c382b4aec3b8e1d8c6"
    },
    {
      "line": 127,
      "relation": "directlyIncreases",
      "evidence": "The reaction with the diagnostic antibodies (Fig. 4) is similar to the examples shown previously for cdk2 (Fig. 2), MAP kinase [8], or GSK-3 [26], indicating the phosphorylation of the SP motifs for which these antibodies are sensitive (serines 199, 202, 235, 396, 404; see Fig. 1)",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 7,
      "target": 10,
      "key": "51ad5c2ddbf8214d2ce5a6176b979943dcead45ebd5de7a82f9489f7ee6c9acb8a1721871c949b1e9ab3f2b1dda105e3c8a5af47f6ecca5372f332a86bd7c19e"
    },
    {
      "line": 128,
      "relation": "directlyIncreases",
      "evidence": "The reaction with the diagnostic antibodies (Fig. 4) is similar to the examples shown previously for cdk2 (Fig. 2), MAP kinase [8], or GSK-3 [26], indicating the phosphorylation of the SP motifs for which these antibodies are sensitive (serines 199, 202, 235, 396, 404; see Fig. 1)",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 7,
      "target": 11,
      "key": "3d78f7f38009ae844f11a01975f7fa02b77e41a359e6cac891e0f2f43f149b8922fac9e35b089b66012e600da9805216a88c7d7fc4ed803c34cd3ab9fc83faf2"
    },
    {
      "line": 129,
      "relation": "directlyIncreases",
      "evidence": "The reaction with the diagnostic antibodies (Fig. 4) is similar to the examples shown previously for cdk2 (Fig. 2), MAP kinase [8], or GSK-3 [26], indicating the phosphorylation of the SP motifs for which these antibodies are sensitive (serines 199, 202, 235, 396, 404; see Fig. 1)",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 7,
      "target": 12,
      "key": "14c77e07369989621f502a072fc843dadad2e08973907e2a66f8529b0c136e93a368ddc7219561825ba87f69a3811c2ee526bc2ac4eefa7609f392778684d7db"
    },
    {
      "line": 130,
      "relation": "directlyIncreases",
      "evidence": "The reaction with the diagnostic antibodies (Fig. 4) is similar to the examples shown previously for cdk2 (Fig. 2), MAP kinase [8], or GSK-3 [26], indicating the phosphorylation of the SP motifs for which these antibodies are sensitive (serines 199, 202, 235, 396, 404; see Fig. 1)",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 7,
      "target": 13,
      "key": "a462eddabef3e7741bd3eb005f7e1c55838a550838d92109398c2b6ce6b69a24d49c6e0d824fd397a7f6d32f0d0c3d6f3abc9dc7d963fd3083449162f2d79aa4"
    },
    {
      "line": 131,
      "relation": "directlyIncreases",
      "evidence": "The reaction with the diagnostic antibodies (Fig. 4) is similar to the examples shown previously for cdk2 (Fig. 2), MAP kinase [8], or GSK-3 [26], indicating the phosphorylation of the SP motifs for which these antibodies are sensitive (serines 199, 202, 235, 396, 404; see Fig. 1)",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 7,
      "target": 14,
      "key": "c3f432df4d90fa2fcca5a3b450681aeaf2d624844093f98b61fde28b04b63193508f9849c3fbdb8d1f4190160c89cc5bae2885f6f4654ed35cb78e753e7b6d45"
    },
    {
      "line": 148,
      "relation": "association",
      "evidence": "Fig. 5 shows that the 31 kDa kinase is included in the MAP fraction after three or more cycles of microtubule assembly (lanes l-6), and is also associated with PHFs (lane 7)",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 7,
      "target": 0,
      "key": "06465f85f3bdebaa71d2e34fe506cbc524335c580d74f8099c81686dba8cb12e1ebc2e64c717d85ed340216c7b1ade3dbc1a335c073e2c6687f692333186f7d4"
    },
    {
      "line": 149,
      "relation": "association",
      "evidence": "Fig. 5 shows that the 31 kDa kinase is included in the MAP fraction after three or more cycles of microtubule assembly (lanes l-6), and is also associated with PHFs (lane 7)",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 7,
      "target": 1,
      "key": "cd8b71e376e378faed17e126401155581fa3775abe6324a3a808dc736b3bc851ed338a3d0f861b6073013146f0e379d07ac38e51f5e7e8de4de477f314b4ccf2"
    },
    {
      "line": 169,
      "relation": "increases",
      "evidence": "Thus, we now know three kinases, cdk5, MAP kinase, and GSK-3, all of which are present in neurons, which are capable of transforming tau into the Alzheimer-like state, and therefore could account for the pathological phosphorylation of tau in Alzheimer brains",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Confidence": {
          "High": true
        }
      },
      "source": 7,
      "target": 19,
      "key": "36d52a3773c54ab43c2f4367973b482a254e3e2bce0c9d56786651b31f55a99bfbfe0b164f80dc78cedb82002e4b85fb21474fae966ac336b6f5e2675f11af5c"
    },
    {
      "line": 171,
      "relation": "positiveCorrelation",
      "evidence": "Thus, we now know three kinases, cdk5, MAP kinase, and GSK-3, all of which are present in neurons, which are capable of transforming tau into the Alzheimer-like state, and therefore could account for the pathological phosphorylation of tau in Alzheimer brains",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Confidence": {
          "High": true
        }
      },
      "source": 7,
      "target": 18,
      "key": "dfaef41f552f6f41488206c556c5560793ac6e0e9248890738034b5960457fa39bfabee94c5105843ab32d7f2c34367c160574b17bf37424d7a17144aef09af4"
    },
    {
      "relation": "hasVariant",
      "source": 4,
      "target": 5,
      "key": "43d2d3f2e7980bac5ebe7409fc1581aceb1ca3ba7c8456be293542b5e6afa9560242f7c6c33a72a99d8ca340e1f5f75bd076543b63d1549de1174df3ff62f2ae"
    },
    {
      "line": 98,
      "relation": "directlyIncreases",
      "evidence": "These fractions (7-9) contained several protein bands, including two with Mr = 25 and 31 kDa (Fig. 3D, lanes 3-5) and were capable of phosphorylating htau40, incorporating 3.2, 4.2 and 2.9 mol Pi per mol htau40, respectively, and inducing an A4, shift of htau40 in SDS-PAGE",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 2,
      "target": 5,
      "key": "d7a7a2e3b1636479f0e7c9236d0519251cd25451bd30e3f8d7c03db5a86a9c40541805edf7533733a5baea743b055a0483e975960e0c4961b8e3c443882a00c3"
    },
    {
      "relation": "hasComponent",
      "source": 3,
      "target": 2,
      "key": "9ca22a39c77be1bf30cff75eb26f89195f70e6c858f9d7def73a729d4a91273f78cdc227788e798ec60d475c8584af05af5c59ddca443d60531638accd07c7eb"
    },
    {
      "relation": "hasComponent",
      "source": 3,
      "target": 7,
      "key": "c239f416ab6880a4c037b2c5db9dfa95c854b09de739f11f5fbd3fe756d11104ed3c2c689d35f41ad01270a6c003f8e1989a66c9c2ee0e5190b466df57b808e9"
    },
    {
      "line": 114,
      "relation": "increases",
      "evidence": "We find that this kinase shows good activity towards tau only when complexed with another protein of Mr 25 kDa, presumably a regulatory subunit analogous to one of the cyclins",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 3,
      "target": 9,
      "key": "2d611abafa97fcbac7d7fe89fea067284ca89694bb5f1b11a52d3e8aa7dccd2a5365415b6d4675cb45ee4da8e081fcd98de3af242569f7b23b337ff79f177ab2"
    },
    {
      "line": 148,
      "relation": "association",
      "evidence": "Fig. 5 shows that the 31 kDa kinase is included in the MAP fraction after three or more cycles of microtubule assembly (lanes l-6), and is also associated with PHFs (lane 7)",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 0,
      "target": 7,
      "key": "a1d4396e6834f5f6549a711f4c921f299981b7365ff363d13694870a381c4880fefafc429b47a2e95ecbb7bb3e752fd1db6c4e5e13faba8c163047421886844c"
    },
    {
      "line": 156,
      "relation": "association",
      "evidence": "In this regard, cdk5 is similar to PKA [30], MAP kinase, and GSK-3 [12,17,26], but distinct from PKC or CaMK which do not copurify with microtubules [34]",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 0,
      "target": 15,
      "key": "d6f3673ae42b27afa28da02584c23206add59bc7ae67b771be8a2da61aec0e690c1b44198c54151eeb358ac38692482dd834125b23c233005aca1b7361691e5d"
    },
    {
      "line": 158,
      "relation": "association",
      "evidence": "In this regard, cdk5 is similar to PKA [30], MAP kinase, and GSK-3 [12,17,26], but distinct from PKC or CaMK which do not copurify with microtubules [34]",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 0,
      "target": 17,
      "key": "32c9b0e29b4a88953866df548921631b741b86f5b120680a3d4ad8367d43e7edb91d81bfd6149afba4c35e4457b18f1118d9a084194d765ba121c7069976a95e"
    },
    {
      "line": 160,
      "relation": "association",
      "evidence": "In this regard, cdk5 is similar to PKA [30], MAP kinase, and GSK-3 [12,17,26], but distinct from PKC or CaMK which do not copurify with microtubules [34]",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 0,
      "target": 16,
      "key": "51c9dfbfdff4d294e6ed07e799cf98e11f67b7512d4b9800679cb3cfb03b9ccf4b9e786d0bbfce0b640d1bfedd8c2e9a8204cc6b895ee1f918a566064ab404dd"
    },
    {
      "line": 149,
      "relation": "association",
      "evidence": "Fig. 5 shows that the 31 kDa kinase is included in the MAP fraction after three or more cycles of microtubule assembly (lanes l-6), and is also associated with PHFs (lane 7)",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 1,
      "target": 7,
      "key": "e41236b7544ac0344f2897227899cc18d8002ee304df6e16d8674ec8a7bf957b80e56de89a1153d5d079789d5a0a301c1ef32c3678a305f603847e10ffa4e3c8"
    },
    {
      "line": 157,
      "relation": "association",
      "evidence": "In this regard, cdk5 is similar to PKA [30], MAP kinase, and GSK-3 [12,17,26], but distinct from PKC or CaMK which do not copurify with microtubules [34]",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 1,
      "target": 15,
      "key": "b4ea1b11a8f1f4200514a1bfe8fcce3332fd23c824270d9549422c0191d9c3d09af4b079233b7c73eb34ca50160260fb7bb1ae40874888ddc4283c42f5da984a"
    },
    {
      "line": 159,
      "relation": "association",
      "evidence": "In this regard, cdk5 is similar to PKA [30], MAP kinase, and GSK-3 [12,17,26], but distinct from PKC or CaMK which do not copurify with microtubules [34]",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 1,
      "target": 17,
      "key": "00baca89f64ed7465ec2d5bb794cb9b5cf8fd559f8a4782cc8a48e8d0a32187e0172494c81e07a2ee382ee2040d39f6ad6a60bfe45b4c2545ab1d2bcb0dca760"
    },
    {
      "line": 161,
      "relation": "association",
      "evidence": "In this regard, cdk5 is similar to PKA [30], MAP kinase, and GSK-3 [12,17,26], but distinct from PKC or CaMK which do not copurify with microtubules [34]",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 1,
      "target": 16,
      "key": "9ba89d73c48f7b71da6d10a2cab859bcff0c8ad71d9032575ecd6874a43010dd52964e3de77e37a01ee209de76ed5dc3d8ec76cb826d93c72c35287722196374"
    },
    {
      "line": 156,
      "relation": "association",
      "evidence": "In this regard, cdk5 is similar to PKA [30], MAP kinase, and GSK-3 [12,17,26], but distinct from PKC or CaMK which do not copurify with microtubules [34]",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 15,
      "target": 0,
      "key": "f366100ec9daa0cd8f1db83ffeb6f6bda2bc762a6f4975b2334fd68d93407a0ec6075e45ecc49153cac28504dad05cc5afc98c32f84f3d319d2b95459a942f3a"
    },
    {
      "line": 157,
      "relation": "association",
      "evidence": "In this regard, cdk5 is similar to PKA [30], MAP kinase, and GSK-3 [12,17,26], but distinct from PKC or CaMK which do not copurify with microtubules [34]",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 15,
      "target": 1,
      "key": "e8a8442dbfd647b50dd9c2ec764ab8d10afcf56ce2ed7c1ae9d4180eefa8b7f859e35894ce959326f512ade95cd730e757d4d7d9dd91917504155d72b382d564"
    },
    {
      "relation": "hasReactant",
      "source": 19,
      "target": 8,
      "key": "03c5b41fbe308fa4b0ee44d61178b87e41fa975b1c1af41f338037a62db08c5ecc4ba7a9d7d47b88fb16336d7737bc1e6aea5c41c5113dc64afdcf8c248d674b"
    },
    {
      "relation": "hasProduct",
      "source": 19,
      "target": 9,
      "key": "562e9e67c936ec93a32dc9546298ad408ec8c717fdb5dcbf04b07b7aeb410d1a9593bc1aa2f56c9513169f60d04e4d273a420f8f467bae1e2b349f1f11c4ddc1"
    },
    {
      "line": 170,
      "relation": "positiveCorrelation",
      "evidence": "Thus, we now know three kinases, cdk5, MAP kinase, and GSK-3, all of which are present in neurons, which are capable of transforming tau into the Alzheimer-like state, and therefore could account for the pathological phosphorylation of tau in Alzheimer brains",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Confidence": {
          "High": true
        }
      },
      "source": 18,
      "target": 9,
      "key": "5d495d018ca134a5e73a9657e6c833703226dd5917c3581b6286f6b91a5ef68c2f151c3c92efcbff324c36ddedd65dd004b46128cfd3e117b870a4dc6b3a2553"
    },
    {
      "line": 171,
      "relation": "positiveCorrelation",
      "evidence": "Thus, we now know three kinases, cdk5, MAP kinase, and GSK-3, all of which are present in neurons, which are capable of transforming tau into the Alzheimer-like state, and therefore could account for the pathological phosphorylation of tau in Alzheimer brains",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Confidence": {
          "High": true
        }
      },
      "source": 18,
      "target": 7,
      "key": "f05f221f0e0be4d80a50a229271535e2ee4e9f53eaffe7bde67b27409eea855878169211eff47d8da60fb28031d4906d1276d835c7361890de657e4d67a8deba"
    },
    {
      "line": 173,
      "relation": "positiveCorrelation",
      "evidence": "Thus, we now know three kinases, cdk5, MAP kinase, and GSK-3, all of which are present in neurons, which are capable of transforming tau into the Alzheimer-like state, and therefore could account for the pathological phosphorylation of tau in Alzheimer brains",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Confidence": {
          "High": true
        }
      },
      "source": 18,
      "target": 17,
      "key": "d74085a65aa5be1e27730962ac3af4a593e94e535a365f07ecf49c73c149c1506741c7579098da863ab01312dd984e1ba0a39dcb30aff314eafce936460e5a9f"
    },
    {
      "line": 175,
      "relation": "positiveCorrelation",
      "evidence": "Thus, we now know three kinases, cdk5, MAP kinase, and GSK-3, all of which are present in neurons, which are capable of transforming tau into the Alzheimer-like state, and therefore could account for the pathological phosphorylation of tau in Alzheimer brains",
      "citation": {
        "type": "PubMed",
        "reference": "8282104"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Confidence": {
          "High": true
        }
      },
      "source": 18,
      "target": 16,
      "key": "66077acb1d7905d919687cfff9e5aea2620b543954dba446510361324a34aa0e00c37d3e6dc214c82a5b25ef25370ef350f4b92235d5aefece163018f7141885"
    }
  ]
}